Steven Bellon
Chief Tech/Sci/R&D Officer chez FOGHORN THERAPEUTICS INC.
Fortune : 1 M $ au 31/03/2024
Profil
Steven F.
Bellon is currently the Chief Scientific Officer at Foghorn Therapeutics, Inc. He previously worked as the Executive Director & Head-Structural Biology at Constellation Pharmaceuticals, Inc. from 2008 to 2016.
Dr. Bellon holds a doctorate degree from the Massachusetts Institute of Technology, which he obtained in 1992.
He also has an undergraduate degree from Haverford College, which he received in 1987.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/02/2024 | 171 957 ( 0,40% ) | 1 M $ | 31/03/2024 |
Postes actifs de Steven Bellon
| Sociétés | Poste | Début |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 10/01/2022 |
Anciens postes connus de Steven Bellon
| Sociétés | Poste | Fin |
|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | Director/Board Member | 01/05/2016 |
Formation de Steven Bellon
| Massachusetts Institute of Technology | Doctorate Degree |
| Haverford College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FOGHORN THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
